Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 183

1.

The orphan nuclear receptor EAR-2 (NR2F6) inhibits hematopoietic cell differentiation and induces myeloid dysplasia in vivo.

Ichim CV, Dervovic DD, Chan LSA, Robertson CJ, Chesney A, Reis MD, Wells RA.

Biomark Res. 2018 Dec 7;6:36. doi: 10.1186/s40364-018-0149-4. eCollection 2018.

2.

OPCML is hypermethylated in a subset of patients with metaplastic changes in their esophagus.

Castaño-Rodríguez N, Popple GL, Porras-Hurtado GL, Cardona-Deazza JL, Montoya-Martinez JJ, Cadavid-Velez AJ, Toro-Hidalgo HW, Cobo-Alvarado AR, Del Socorro Hincapié-Rincón O, Riordan SM, Kaakoush NO.

Biomark Res. 2018 Dec 7;6:35. doi: 10.1186/s40364-018-0150-y. eCollection 2018.

3.

EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies.

Tremblay-LeMay R, Rastgoo N, Pourabdollah M, Chang H.

Biomark Res. 2018 Dec 7;6:34. doi: 10.1186/s40364-018-0148-5. eCollection 2018. Review.

4.

Philadelphia chromosome positive AML arising from JAK2-positive myelofibrosis.

Brattås MK, Lilleeng K, Hovland R, Lægreid IJ, Vorland M, Leh F, Bruserud Ø, Gjertsen BT, Reikvam H.

Biomark Res. 2018 Nov 21;6:33. doi: 10.1186/s40364-018-0147-6. eCollection 2018.

5.

Molecular landscape and targeted therapy of acute myeloid leukemia.

Gu R, Yang X, Wei H.

Biomark Res. 2018 Nov 8;6:32. doi: 10.1186/s40364-018-0146-7. eCollection 2018. Review.

6.

Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts.

Agnoletto C, Minotti L, Brulle-Soumare L, Pasquali L, Galasso M, Corrà F, Baldassari F, Judde JG, Cairo S, Volinia S.

Biomark Res. 2018 Oct 30;6:31. doi: 10.1186/s40364-018-0145-8. eCollection 2018.

7.

Overexpression and cytoplasmic localization of caspase-6 is associated with lamin A degradation in set of ovarian cancers.

Capo-Chichi CD, Cai KQ, Xu XX.

Biomark Res. 2018 Oct 30;6:30. doi: 10.1186/s40364-018-0144-9. eCollection 2018.

8.

SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms.

Aujla A, Linder K, Iragavarapu C, Karass M, Liu D.

Biomark Res. 2018 Sep 26;6:29. doi: 10.1186/s40364-018-0142-y. eCollection 2018. Review.

9.

Aptamer-based search for correlates of plasma and serum water T2: implications for early metabolic dysregulation and metabolic syndrome.

Patel V, Dwivedi AK, Deodhar S, Mishra I, Cistola DP.

Biomark Res. 2018 Sep 17;6:28. doi: 10.1186/s40364-018-0143-x. eCollection 2018.

10.

Dysregulated transcriptional networks in KMT2A- and MLLT10-rearranged T-ALL.

Kang H, Sharma ND, Nickl CK, Devidas M, Loh ML, Hunger SP, Dunsmore KP, Winter SS, Matlawska-Wasowska K.

Biomark Res. 2018 Aug 23;6:27. doi: 10.1186/s40364-018-0141-z. eCollection 2018.

11.

Combination statin and chemotherapy inhibits proliferation and cytotoxicity of an aggressive natural killer cell leukemia.

Henslee AB, Steele TA.

Biomark Res. 2018 Aug 9;6:26. doi: 10.1186/s40364-018-0140-0. eCollection 2018.

12.

Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinoma.

Yang MX, Coates RF, Ambaye A, Gardner JA, Zubarick R, Gao Y, Skelly J, Liu JG, Mino-Kenudson M.

Biomark Res. 2018 Jul 27;6:25. doi: 10.1186/s40364-018-0139-6. eCollection 2018.

13.

Phosphatidylinositol 3-kinase-δ (PI3K-δ) is a potential therapeutic target in adult T-cell leukemia-lymphoma.

Katsuya H, Cook LBM, Rowan AG, Satou Y, Taylor GP, Bangham CRM.

Biomark Res. 2018 Jul 18;6:24. doi: 10.1186/s40364-018-0138-7. eCollection 2018.

14.

Fibronectin protein expression in renal cell carcinoma in correlation with clinical stage of tumour.

Kondisetty S, Menon KN, Pooleri GK.

Biomark Res. 2018 Jul 11;6:23. doi: 10.1186/s40364-018-0137-8. eCollection 2018.

15.

Kinomic profiling of glioblastoma cells reveals PLCG1 as a target in restricted glucose.

Walker K, Boyd NH, Anderson JC, Willey CD, Hjelmeland AB.

Biomark Res. 2018 Jun 14;6:22. doi: 10.1186/s40364-018-0136-9. eCollection 2018.

16.

Chemerin is elevated in multiple myeloma patients and is expressed by stromal cells and pre-adipocytes.

Westhrin M, Moen SH, Kristensen IB, Buene G, Mylin AK, Turesson I, Abildgaard N, Waage A, Standal T.

Biomark Res. 2018 Jun 14;6:21. doi: 10.1186/s40364-018-0134-y. eCollection 2018.

17.

Serum levels of VEGF and MCSF in HER2+ / HER2- breast cancer patients with metronomic neoadjuvant chemotherapy.

Arai RJ, Petry V, Hoff PM, Mano MS.

Biomark Res. 2018 Jun 14;6:20. doi: 10.1186/s40364-018-0135-x. eCollection 2018.

18.

microRNA based prognostic biomarkers in pancreatic Cancer.

Guo S, Fesler A, Wang H, Ju J.

Biomark Res. 2018 May 21;6:18. doi: 10.1186/s40364-018-0131-1. eCollection 2018. Review.

19.

Associations of single nucleotide polymorphisms with mucinous colorectal cancer: genome-wide common variant and gene-based rare variant analyses.

Penney ME, Parfrey PS, Savas S, Yilmaz YE.

Biomark Res. 2018 Jun 13;6:17. doi: 10.1186/s40364-018-0133-z. eCollection 2018.

20.

Absence of calretinin protein expression in malignant mesotheliomas from asbestos-exposed NF2+/- mice and mouse mesothelioma cell lines from various mouse strains.

Blum W, Henzi T, Châtel-Soulet HE, Pecze L, Rodriguez JW, Vrugt B, Schwaller B.

Biomark Res. 2018 Jun 6;6:19. doi: 10.1186/s40364-018-0132-0. eCollection 2018.

Supplemental Content

Loading ...
Support Center